JIMENEZ-QUEVEDO P, GONZALEZ-FERRER JJ, SABATE M, GARCIA-MOLL X, DELGADO-BOLTON RC, LLORENTE L, BERNARDO E, ORTEGA-POZZI A, HERNÁNDEZ-ANTOLIN R, ALFONSO F, GONZALO N, ESCANED J, BAÑUELOS C, REGUEIRO A, MARIN P, FERNÁNDEZ-ORTIZ A, DAS-NEVES B, DEL TRIGO M, FERNÁNDEZ C, TEJERINA T, REDONDO S, GARCÍA E, MACAYA C. Selected CD133+ Progenitor Cells to Promote Angiogenesis in Patients with Refractory Angina: The Final Results of the PROGENITOR Randomized Trial. Circulation Research. 2014; 115(11): 950-960.                                                                                                                                                              F. IMPACTO: 11.019

 

ARGÜELLES-ARIAS F, BARREIRO-DE-ACOSTA M, CARBALLO F, HINOJOSA J, TEJERINA T. New contributions to consensus on biosimilars. Rev Esp Enferm Dig. 2014; 106(3):228-229                                                       F. IMPACTO: 1.414

 

ARGÜELLES-ARIAS F, BARREIRO-DE-ACOSTA M, CARBALLO F, HINOJOSA J, TEJERINA T. Biosimilar therapy for inflammatory bowel disease. Rev Esp Enferm Dig. 2014; 106(1):67-68                                                       F. IMPACTO: 1.414

 

NAVARRO-DORADO J, GARCIA-ALONSO M, VAN BREEMEN C, TEJERINA T, FAMELI N. Calcium oscillations in human mesenteric vascular smooth muscle.  Biochem Biophys Res Commun. 2014; 455(1):84-88                                                                  F. IMPACTO: 2.297

 

REDONDO S, NAVARRO-DORADO J, RAMAJO M, MEDINA U, MOLINA-SANCHEZ P, GARCES Z, ALONSO M, REGUILLO F, RODRIGUEZ E, ANDRES V, TEJERINA T. Age-dependent defective TGF-beta1 signaling in patients undergoing coronary artery bypass grafting. J Cardiothorac Surg. 2014 Vol.: 9(1)                                                                                            F. IMPACTO: 1.018

 

GORDILLO-MOSCOSO A, RUIZ E, CARNERO M, REGUILLO F, RODRIGUEZ E, TEJERINA T, REDONDO S. Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: a translational study. Lipids Health Dis. 2013; 12(62)                                                                                      F. IMPACTO: 2.310

 

ARGÜELLES-ARIAS, F.; BARREIRO-DEACOSTA, M.; CARBALLO, F.; HINOJOSA, J.; TEJERINA, T. Joint position statement by Sphanish Society of Gastroenterology and Spanish Society of Pharmacology on biosimilar therapy for inflammatory bowel disease. Revista española de enfermedades digestivas. 2013; 105(1): 37-43             F. IMPACTO: 1.317

 

AGUADO, A.; GALÁN, M.; ZHENYUKH, O.; WIGGERS, GA.; ROQUE, FR.; REDONDO, S.; PEÇANHA, F.; MARTÍN, A.; FORTUÑO, A.; CACHOFEIRO, V.; TEJERINA, T.; SALAICES, M.; BRIONES, AM. Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways. Toxicology and applied pharmacology. 2013; 268(2): 188-200                                                                     F. IMPACTO: 3.630

 

CARNERO-ALCÁZAR M, SILVA GUISASOLA JA, REGUILLO LACRUZ FJ, MAROTO CASTELLANOS LC, COBIELLA CARNICER J, VILLAGRÁN MEDINILLA E, TEJERINA SÁNCHEZ T, RODRÍGUEZ HERNÁNDEZ JE. Validation of EuroSCORE II on a single-centre 3800 patient cohort. Interact Cardiovasc Thorac Surg. 2013; 16(3): 293-300                                                              F. IMPACTO: 1.112

 

REDONDO S, NAVARRO-DORADO J, RAMAJO M, MEDINA Ú, TEJERINA T. The complex regulation of TGF-β in cardiovascular disease. Vasc Health Risk Manag. 2012; 8: 533-539                                                              F. IMPACTO: 0.77

GÓMEZ-GARRE D, ESTRADA V, ORTEGA-HERNÁNDEZ A, MUÑOZ-PACHECO P, SERRANO-VILLAR S, AVILA M, FUENTES-FERRER M, TEJERINA T, FERNÁNDEZ-CRUZ A. Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis. J Acquir Immune Defic Syndr. 2012; 61(5): 545-51                                                                     F. IMPACTO: 4.653

 

S. REDONDO; U. MEDINA; J. NAVARRO-DORADO; M. RAMAJO; T. TEJERINA  Denosumab en el tratamiento de la osteoporosis posmenopaúsica y de la pérdida de masa ósea en pacientes con deprivación androgénica. Revista Rev Act Farmacol Terp. 2012; 10(1): 17-27                                                     

 

RAMAJO, M.; REDONDO, S.; GONZALEZ-ROCAFORT, A.; NAVARO-DORADO, J.; REGUILLO, F.; CARNERO, M.; MARTÍNEZ-GONZALEZ, J.; RODRIGUEZ, E.; TEJERINA, T. La depleción de células CD34+/CD144+ en pacientes de revascularización miocárdica no está mediada por un aumento de la apoptosis inducida por el TGF-beta plasmático. Clínica e Investigación en Arteriosclerosis. 2012; 24(1): 12-20.                                                                                  F. IMPACTO: 0.13

 

CARNERO-ALCÁZAR M, ALSWAIS A, VALLAGRÁN MEDINILLA E, MAROTO LC, SILVA GUISASOLA JA, COBIELLA CARNIER J, TEJERINA SÁNCHEZ MT, RODRÍGUEZ HERNÁNDEZ JE. Mid-term outcomes alter off-pump coronary surgery in patients with prior intracoronary stent. Eur J Cardiothorac Surg. 2012; 41(6): 1295-1303.                                                                     F.  IMPACTO: 2.674

 

REDONDO, S.; GONZALEZ-ROCAFORT, A.; NAVARRO-DORADO, J.; RAMAJO, M.; KRISTOV, M.; GORDILLO-MOSCOSO, A.; REGUILLO, F.; CARNERO, M.; MARTÍNEZGONZALEZ, J.; RODRIGUEZ, E.; WEBER, C.; TEJERINA, T.

Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients. Journal of Cardiothoracic. 2012; 7(1): 2.                                                                             F. IMPACTO: 0.977

 

DE LA CUESTA, F.; BARDERAS, M. G.; CALVO, E.; ZUBIRI, I.; MAROTO, A. S.; DARDE, V. M.; MARTIN-ROJAS, T.; GIL-DONES, F.; POSADA, M.; TEJERINA, T.; LOPEZ, J. A.; VIVANCO, F.; ALVAREZ-LLAMAS, G. Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracelular remodeling during pathogenesis. J Proteomics. 2012; 75(10): 2960-2971.                                                                                                                  F. IMPACTO: 4.088

 

REDONDO, S.; MARTÍNEZ, M.P; RAMAJO, M.; NAVARRO-DORADO, J.; BAREZ, A.; TEJERINA, T. Pharmacological basis and clinical evidence of dabigatran therapy. Journal of Hematology & Oncology. 2011; 4: 53.                                                               F. IMPACTO: 3.990

 

REDONDO, S.; MARTÍNEZ-GONZALEZ, J.; URRACA, C.; TEJERINA, T. Emerging therapeutic strategies to enhance HDL function. Lipids in Health and Disease. 2011; 10: 175.                                                                                  F. IMPACTO: 2.170

 

REDONDO, S.; RUIZ, E.; GORDILLO-MOSCOSO, A.; NAVARO-DORADO, J.; RAMAJO, M.; RODRIGUEZ, E.; REGUILLO, F.; CARNERO, M.; CASADO, M.; TEJERINA, T. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis. Diabetologia. 2011; 54(1):190-199.                                                                                                  F.  IMPACTO: 6.814